Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics

Anthony J. Hickey, Heidi - Mansour, Martin J. Telko, Zhen Xu, Hugh D C Smyth, Tako Mulder, Richard Mclean, John Langridge, Dimitris Papadopoulos

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

The performance of dry powder aerosols for the delivery of drugs to the lungs has been studied extensively in the last decade. The focus for different research groups has been on aspects of the powder formulation, which relate to solid state, surface and interfacial chemistry, bulk properties (static and dynamic) and measures of performance. The nature of studies in this field, tend to be complex and correlations between specific properties and performance seem to be rare. Consequently, the adoption of formulation approaches that on a predictive basis lead to desirable performance has been an elusive goal but one that many agree is worth striving towards. The purpose of this paper is to initiate a discussion of the use of a variety of techniques to elucidate dry particle behavior that might guide the data collection process. If the many researchers in this field can agree on this, or an alternative, guide then a database can be constructed that would allow predictive models to be developed. This is the first of two papers that discuss static and dynamic methods of characterizing dry powder inhaler formulations.

Original languageEnglish (US)
Pages (from-to)1282-1301
Number of pages20
JournalJournal of Pharmaceutical Sciences
Volume96
Issue number5
DOIs
StatePublished - May 2007
Externally publishedYes

Fingerprint

Dry Powder Inhalers
Powders
Surface chemistry
Aerosols
Research Personnel
Databases
Lung
Research
Pharmaceutical Preparations

Keywords

  • Aerosols
  • Formulation
  • Physical characterization
  • Physicochemical
  • Preformulation
  • Pulmonary
  • Pulmonary drug delivery
  • Solid state
  • Surface chemistry
  • Thermodynamics

ASJC Scopus subject areas

  • Drug Discovery
  • Organic Chemistry
  • Chemistry(all)
  • Molecular Medicine
  • Pharmacology
  • Pharmaceutical Science

Cite this

Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. / Hickey, Anthony J.; Mansour, Heidi -; Telko, Martin J.; Xu, Zhen; Smyth, Hugh D C; Mulder, Tako; Mclean, Richard; Langridge, John; Papadopoulos, Dimitris.

In: Journal of Pharmaceutical Sciences, Vol. 96, No. 5, 05.2007, p. 1282-1301.

Research output: Contribution to journalArticle

Hickey, AJ, Mansour, H, Telko, MJ, Xu, Z, Smyth, HDC, Mulder, T, Mclean, R, Langridge, J & Papadopoulos, D 2007, 'Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics', Journal of Pharmaceutical Sciences, vol. 96, no. 5, pp. 1282-1301. https://doi.org/10.1002/jps.20916
Hickey, Anthony J. ; Mansour, Heidi - ; Telko, Martin J. ; Xu, Zhen ; Smyth, Hugh D C ; Mulder, Tako ; Mclean, Richard ; Langridge, John ; Papadopoulos, Dimitris. / Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics. In: Journal of Pharmaceutical Sciences. 2007 ; Vol. 96, No. 5. pp. 1282-1301.
@article{ad9fd9acb6c94f90829e81266dba19c5,
title = "Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics",
abstract = "The performance of dry powder aerosols for the delivery of drugs to the lungs has been studied extensively in the last decade. The focus for different research groups has been on aspects of the powder formulation, which relate to solid state, surface and interfacial chemistry, bulk properties (static and dynamic) and measures of performance. The nature of studies in this field, tend to be complex and correlations between specific properties and performance seem to be rare. Consequently, the adoption of formulation approaches that on a predictive basis lead to desirable performance has been an elusive goal but one that many agree is worth striving towards. The purpose of this paper is to initiate a discussion of the use of a variety of techniques to elucidate dry particle behavior that might guide the data collection process. If the many researchers in this field can agree on this, or an alternative, guide then a database can be constructed that would allow predictive models to be developed. This is the first of two papers that discuss static and dynamic methods of characterizing dry powder inhaler formulations.",
keywords = "Aerosols, Formulation, Physical characterization, Physicochemical, Preformulation, Pulmonary, Pulmonary drug delivery, Solid state, Surface chemistry, Thermodynamics",
author = "Hickey, {Anthony J.} and Mansour, {Heidi -} and Telko, {Martin J.} and Zhen Xu and Smyth, {Hugh D C} and Tako Mulder and Richard Mclean and John Langridge and Dimitris Papadopoulos",
year = "2007",
month = "5",
doi = "10.1002/jps.20916",
language = "English (US)",
volume = "96",
pages = "1282--1301",
journal = "Journal of Pharmaceutical Sciences",
issn = "0022-3549",
publisher = "John Wiley and Sons Inc.",
number = "5",

}

TY - JOUR

T1 - Physical characterization of component particles included in dry powder inhalers. I. Strategy review and static characteristics

AU - Hickey, Anthony J.

AU - Mansour, Heidi -

AU - Telko, Martin J.

AU - Xu, Zhen

AU - Smyth, Hugh D C

AU - Mulder, Tako

AU - Mclean, Richard

AU - Langridge, John

AU - Papadopoulos, Dimitris

PY - 2007/5

Y1 - 2007/5

N2 - The performance of dry powder aerosols for the delivery of drugs to the lungs has been studied extensively in the last decade. The focus for different research groups has been on aspects of the powder formulation, which relate to solid state, surface and interfacial chemistry, bulk properties (static and dynamic) and measures of performance. The nature of studies in this field, tend to be complex and correlations between specific properties and performance seem to be rare. Consequently, the adoption of formulation approaches that on a predictive basis lead to desirable performance has been an elusive goal but one that many agree is worth striving towards. The purpose of this paper is to initiate a discussion of the use of a variety of techniques to elucidate dry particle behavior that might guide the data collection process. If the many researchers in this field can agree on this, or an alternative, guide then a database can be constructed that would allow predictive models to be developed. This is the first of two papers that discuss static and dynamic methods of characterizing dry powder inhaler formulations.

AB - The performance of dry powder aerosols for the delivery of drugs to the lungs has been studied extensively in the last decade. The focus for different research groups has been on aspects of the powder formulation, which relate to solid state, surface and interfacial chemistry, bulk properties (static and dynamic) and measures of performance. The nature of studies in this field, tend to be complex and correlations between specific properties and performance seem to be rare. Consequently, the adoption of formulation approaches that on a predictive basis lead to desirable performance has been an elusive goal but one that many agree is worth striving towards. The purpose of this paper is to initiate a discussion of the use of a variety of techniques to elucidate dry particle behavior that might guide the data collection process. If the many researchers in this field can agree on this, or an alternative, guide then a database can be constructed that would allow predictive models to be developed. This is the first of two papers that discuss static and dynamic methods of characterizing dry powder inhaler formulations.

KW - Aerosols

KW - Formulation

KW - Physical characterization

KW - Physicochemical

KW - Preformulation

KW - Pulmonary

KW - Pulmonary drug delivery

KW - Solid state

KW - Surface chemistry

KW - Thermodynamics

UR - http://www.scopus.com/inward/record.url?scp=34249300511&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249300511&partnerID=8YFLogxK

U2 - 10.1002/jps.20916

DO - 10.1002/jps.20916

M3 - Article

C2 - 17455324

AN - SCOPUS:34249300511

VL - 96

SP - 1282

EP - 1301

JO - Journal of Pharmaceutical Sciences

JF - Journal of Pharmaceutical Sciences

SN - 0022-3549

IS - 5

ER -